Weight loss following bariatric surgery in women with polycystic ovarian syndrome and oligomenorrhea

2016 ◽  
Vol 12 (7) ◽  
pp. s121-s122
Author(s):  
Sarah Pivo ◽  
Margaret Nachtigall ◽  
Patricia Chui ◽  
Akuezunkpa Ude Welcome ◽  
John Saunders ◽  
...  
Endocrinology ◽  
2011 ◽  
Vol 152 (10) ◽  
pp. 3700-3705 ◽  
Author(s):  
Hilary E. Wilson-Pérez ◽  
Randy J. Seeley

Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder of women of reproductive age. Although some of the primary symptoms of PCOS are reproductive abnormalities, including hyperandrogenism, menstrual dysfunction, and hirsutism, other metabolic disturbances are also common, including obesity and insulin resistance. Women with PCOS who have undergone weight-loss bariatric surgery have reported surprising postoperative benefits beyond weight loss, including resolution of menstrual dysfunction and improvement of hirsutism. Here, we use a chronic dihydrotestosterone (DHT) exposure model of PCOS in female rats and investigate the efficacy of a specific type of bariatric surgery, namely vertical sleeve gastrectomy (VSG), to resolve the reproductive and metabolic disturbances induced by DHT treatment. We find that VSG causes loss of body weight and body fat in DHT-treated rats but does not improve glucose tolerance or restore estrous cyclicity. Although human PCOS patients have shown decreased androgen levels after bariatric surgery, the chronic nature of DHT administration in this rat model both before and after VSG renders this effect impossible in this case. Therefore, the lack of improvement in glucose tolerance and estrous cyclicity may implicate a direct effect of androgen knockdown as a mechanism for the improvements seen in human PCOS patients after bariatric surgery. In addition, the dissociation of body weight loss without improved glucose tolerance suggests that glucose intolerance may be a body weight-independent phenomenon in women with PCOS.


2017 ◽  
Vol 12 (3) ◽  
pp. 91-93
Author(s):  
Arinbjorn Jonsson ◽  
Lava Y. Patel ◽  
Arvinpal Singh ◽  
S. Scott Davis ◽  
Edward Lin

2017 ◽  
Vol 13 (10) ◽  
pp. S15 ◽  
Author(s):  
Joshua Dilday ◽  
Michael Derickson ◽  
John Kuckelman ◽  
Julia Bader ◽  
Eric Ahnfeldt ◽  
...  

2017 ◽  
Vol 87 (2) ◽  
pp. 185-193 ◽  
Author(s):  
Thomas Reinehr ◽  
Alexandra Kulle ◽  
Juliane Rothermel ◽  
Caroline Knop ◽  
Nina Lass ◽  
...  

2017 ◽  
Vol 6 (4) ◽  
pp. 213-224 ◽  
Author(s):  
Thomas Reinehr ◽  
Alexandra Kulle ◽  
Juliane Rothermel ◽  
Caroline Knop-Schmenn ◽  
Nina Lass ◽  
...  

Objective The underlying mechanisms of polycystic ovarian syndrome (PCOS) are not fully understood yet. The aim of the study was to get functional insights into the regulation of steroid hormones in PCOS by steroid metabolomics. Design This is a longitudinal study of changes of steroid hormones in 40 obese girls aged 13–16 years (50% with PCOS) participating in a 1-year lifestyle intervention. Girls with and without PCOS were matched to age, BMI and change of weight status. Methods We measured progesterone, 17-hydroxyprogesterone, 17-hydroxyprogenolon, 11-deoxycorticosterone, 21-deoxycorticosterone, deoxycorticosterone, corticosterone, 11-deoxycortisol, cortisol, cortisone, androstenedione, testosterone, dehydroepiandrostendione-sulfate (DHEA-S), estrone and estradiol by LC–MS/MS steroid profiling at baseline and one year later. Results At baseline, obese PCOS girls demonstrated significantly higher androstenedione and testosterone concentrations compared to obese girls without PCOS, whereas the other steroid hormones including glucocorticoids, mineralocorticoids, estrogens and precursors of androgens did not differ significantly. Weight loss in obese PCOS girls was associated with a significant decrease of testosterone, androstenedione, DHEA-S, cortisol and corticosterone concentrations. Weight loss in obese non-PCOS girls was associated with a significant decrease of DHEA-S, cortisol and corticosterone concentrations, whereas no significant changes of testosterone and androstenedione concentrations could be observed. Without weight loss, no significant changes of steroid hormones were measured except an increase of estradiol in obese PCOS girls without weight loss. Conclusions The key steroid hormones in obese adolescents with PCOS are androstenedione and testosterone, whereas glucocorticoids, mineralocorticoids, estrogens and precursors of androgens did not differ between obese girls with and without PCOS.


2018 ◽  
Vol 12 (6) ◽  
pp. 999-1005 ◽  
Author(s):  
Firass Abiad ◽  
Dalia Khalife ◽  
Bassem Safadi ◽  
Ramzi Alami ◽  
Johnny Awwad ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document